Trial intelligence / Profile preview

Sildenafil for transient tachypnea of the newborn

IRCT20161206031269N2Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in transient tachypnea of the newborn (TTN) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Need for mechanical ventilation. Started Feb 2018; status: completed.

02

Drugs

sildenafil
03

Conditions

transient tachypnea of the newborn (TTN)

Beyond the preview

Go deeper on IRCT20161206031269N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20161206031269N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call